Skip to main content
SpringerLink
Log in

Systemic lupus erythematosus: Clinical manifestations and immunological parameters in 194 patients. Subgroup classification of SLE

  • Originals
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Summary

We analysed the prevalence of clinical manifestations and immunological parameters in 194 patients with SLE and classified them in subgroups according to age at onset, gender and type of antibodies: we detected significant differences in the various subgroups.

In SLE that initiated before the age of 20 years, the most frequent manifestation at onset was malar rash (25% vs 14%). During the course of the disease, this group had a greater prevalence of malar rash (70% vs 45%), mouth ulcers (48% vs 29%), and convulsions or psychosis (35% vs 17%).

In SLE that initiated late in life (after 50 years) malar rash was less frequent at onset and during subsequent evolution of the disease (27% vs 45%). The existence of ANA, and elevated values of anti-dsDNA, anti-ENA and antiphospholipid antibodies also differentiated the SLE subgroups with clinical significance.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Cervera, C., Khamashta, M.A., Font, J., Sebastiani, G.D., Gil, A., Lavilla, P., Domenech, I., Aydintug, A.O., Jedryka-Goral, A., Ramon, E., Galeazzi, M., Haga, H.J., Mathieu, A., Houssiau, F., Ingelmo, M., Hughes, G.R.V., and the European Working Party on Systemic Lupus Erythematosus. Systemic Lupus Erythematosus: Clinical and immunologic patterns of disease expression in a cohort of 1000 patients. Medicine 1973, 72, 113–124.

    Google Scholar 

  2. Ballou, S.P., Khan, M.A., Kushner, I. Clinical features of systemic lupus erythematosus: Differences related to race and age of onset. Arthritis Rheum 1982, 25, 55–60.

    PubMed  Google Scholar 

  3. Ward, M.M., Studenski, S. Systemic lupus erythematosus in men: A multivariate analysis of gender differences in clinical manifestations. J Rheumatol 1990, 17, 220–224.

    PubMed  Google Scholar 

  4. Tan, E.M., Cohen, A.S., Fries, J.F., Masi, A.T., McShane, D.J., Rohtfield, N.F., Schaller, J.G., Talal, N., Winchester, R.J. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982, 25, 1271–1277.

    PubMed  Google Scholar 

  5. Grishman, E., Gerber, M.A., Churg, J. Patterns of renal injury in systemic lupus erythematosus: Light and immunofluorescence microscopic observations. Am J Kid Dis 1982, 2, 135–141.

    PubMed  Google Scholar 

  6. Gharavi, A.E., Harris, E.N., Asherson, R.A., Hughes, G.R.V. Anticardiolipin antibodies: Isotype distribution and phospholipid specificity. Ann Rheum Dis 1987, 46, 1–6.

    PubMed  Google Scholar 

  7. Dubois, E.L., Wallance, D.J. Clinical and laboratory manifestations of systemic lupus erythematosus. In: Dubois' Lupus Erythematosus. 3rd ed. Eds.: Wallance, D.J., Dubois, E.L. Philadelphia, Lea and Febiger 1987, 317–449.

    Google Scholar 

  8. Fessel, W.J. Systemic lupus erythematosus in the community. Incidence, prevalence, outcome, and first symptoms; the high prevalence in black women. Arch Intern Med 1974, 134, 1027–1035.

    PubMed  Google Scholar 

  9. Pines, A., Kaplinsky, N., Olchovsky, D., Rozenman, J., Frankl, O. Pleuro-pulmonary manifestations of systemic lupus erythematosus: clinical features of its subgroups. Prognostic and therapeutic implications. Chest 1985, 88, 129–135.

    PubMed  Google Scholar 

  10. Baldwin, D.S., Gluck, M.C., Lowenstein, J., Gallo, G.R. Lupus nephritis: clinical course as related to morphologic forms and their transitions. Am J Med 1977, 62, 12–20.

    PubMed  Google Scholar 

  11. Estes, D., Christian, C.L. The natural history of systemic lupus erythematosus by prospective analysis. Medicine 1971, 50, 85–95.

    PubMed  Google Scholar 

  12. Nepom, B.S., Schaller, J.G. Childhood systemic lupus erythematosus. Prog Clin Rheumatol 1984, 1, 33–69.

    Google Scholar 

  13. Schaller, J. Lupus in Childhood. Clin Rheum Dis 1982, 8, 219–228.

    PubMed  Google Scholar 

  14. Ting, C.K., Hsieh, Kh. A long term immunological study of childhood onset systemic lupus erythematosus. Ann Rheum Dis 1992, 51, 45–51.

    PubMed  Google Scholar 

  15. Baker, S.B., Rovira, J.R., Campion, E.W., Mills, J.A. Late onset systemic lupus erythematosus. Am J Med 1979, 66, 727–732.

    PubMed  Google Scholar 

  16. Catoggio, L.J., Skinner, R.P., Smith, G., Maddison, P.J. Systemic lupus erythematosus in the elderly: Clinical and serological characteristics. J Rheumatol 1984, 11, 175–181.

    PubMed  Google Scholar 

  17. Dimant, J., Ginzler, E.M., Schelinger, M., Diamond, H.S., Kaplan, D. Systemic lupus erythematosus in the older age group: Computer analysis. J Am Geriatr Soc 1979, 27, 58–61.

    PubMed  Google Scholar 

  18. Foad, B.S.I., Sheon, R.P., Kirsner, A.B. Systemic lupus erythematosus in the elderly. Arch Intern Med 1972, 130, 743–746.

    PubMed  Google Scholar 

  19. Jonsson, H., Nived, O., Sturfelt, G. The effect of age on clinical and serological manifestations in unselected patients with systemic lupus erythematosus. J Rheumatol 1988, 15, 505–509.

    PubMed  Google Scholar 

  20. Maddison, P.J. Systemic lupus erythematosus in the elderly. J Rheumatol 1987, 14 (Suppl 13), 182–187.

    PubMed  Google Scholar 

  21. Salem, B., Foad, I., Sheon, R.P., Kirnser, A.B. Systemic lupus erythematosus in the elderly. Arch Intern Med 1972, 130, 743–746.

    PubMed  Google Scholar 

  22. Urowitz, M.B., Stevens, M.B., Shulman, L.E. The influence of age in the clinical pattern of systemic lupus erythematosus. Arthritis Rheum 1967, 10, 319–320.

    Google Scholar 

  23. Wilson, H.A., Hamilton, M.E., Spyker, D.A., Brunner, C.M., O'Brien, W.M., Davies JS, Winfield JB Age influences the clinical and serological expression of systemic lupus erythematosus. Arthritis Rheum 1981, 24, 1230–1235.

    PubMed  Google Scholar 

  24. Miller, M.H., Urowitz, M.B., Gladman, D.D., Killinger, D.W. Systemic lupus erythematosus in males. Medicine 1983, 62, 327–334.

    PubMed  Google Scholar 

  25. Blum, A., Rubinow, A., Galun, E. Predominance of renal involvement in male patients with systemic lupus erythematosus. Clin Exp Rheumatol 1991, 9, 206–207.

    PubMed  Google Scholar 

  26. Inman, R.D., Jovanovic, L., Markenson, J.A., Longcope, C., Dawood, M.Y., Lockshin, M.D. Systemic lupus erythematosus in men. Genetic and endocrine features. Arch Intern Med 1982, 142, 1813–1815.

    PubMed  Google Scholar 

  27. Fessel, W.J. ANA-negative systemic lupus erythematosus. Am J Med 1978, 64, 80–86.

    PubMed  Google Scholar 

  28. Maddison, P.J., Provost, T.T., Reichlin, M. Serological findings in patients with ANA-negative systemic lupus erythematosus. Medicine 60, 87–94, 1981.

    PubMed  Google Scholar 

  29. LLoyd, W., Schur, P.H. Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). Medicine 1981, 60, 208–217.

    PubMed  Google Scholar 

  30. Ader, M.K., Baumgarten, A., Hecht, B., Siegel, N.J. Prognostic significance of DNA-binding capacity patterns in patients with lupus nephritis. Ann Rheum Dis 1975, 34, 444–450.

    PubMed  Google Scholar 

  31. Mond, C.B., Peterson, M.G.E., Rothfield, N.F. Correlation of anti-Ro antibody with photosensitivity rash in systemic lupus erythematosus patients. Arthritis Rheum 1989, 32, 202–204.

    PubMed  Google Scholar 

  32. Maddison, P.J., Isenberg, D.A., Goulding, N.J., Leddy, J., Skinner, R.P. Anti-La(SSB) identifies a distinctive subgroup of systemic lupus erythematosus. Br J Rheumatol 1988, 27, 27–31.

    PubMed  Google Scholar 

  33. Gaudreau, A., Amor, B., Khan, M.F., Ryckewacrt, A., Sany, J., Peltier, A.P. Clinical significance of antibodies to soluble extractable nuclear antigens (anti-ENA) Ann Rheum Dis 1978, 37, 321–327.

    PubMed  Google Scholar 

  34. Clotet, B., Guardia, J., Pigrau, C., Lience, E., Murcia, C., Pujol, R., Bacardi, R. Incidence and clinical significance of antiENA antibodies in systemic lupus erythematosus. Estimation by counterimmunoelectrophoresis. Scan J Rheum 1984, 13, 15–20.

    Google Scholar 

  35. Asherson, R.A., Khamashta, M.A., Gil, A., Vázquez, J.J., Chan, O., Baguley, E., Hughes, G.R.V. Cerebrovascular disease and antipholipid antibodies in systemic lupus erythematosus, lupuslike disease, and the primary antiphospholipid syndrome. Am J Med 1989, 86, 391–399.

    PubMed  Google Scholar 

  36. Harris, E.N., Gharavi, A.E., Boey, M.L. et al. Anticardiolipin antibodies: detection by radioinmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983, 2, 1211–1214.

    PubMed  Google Scholar 

  37. Cervera, R., Font, J., Lopez-Soto, A., Casals, F., Pallares, L., Bove, A., Ingelmo, M., Urbano-Marquez, A. Isotype distribution of anticardiolipin antibodies in systemic lupus erythematosus: prospective analysis of a series of 100 patients. Ann Rheum Dis 1990, 49, 109–113.

    PubMed  Google Scholar 

  38. Meyer, O., Piette, J.C., Bourgeois, P., Fallas, P., Bletry, O., Jungers, P., Kahn, M.F., Godeau, P., Ryckewaert, A. Antiphospholipid antibodies: a disease marker in 25 patients with antinuclear antibody negative systemic lupus erythematosus (SLE). Comparison with a group of 91 patients with antinuclear antibody positive SLE. J Rheumatol 1987, 14, 502–506.

    PubMed  Google Scholar 

  39. Espinoza, L.R., Hartmann, R.C. Significance of the lupus anticoagulant. Am J Hematol 1986, 22, 331–337.

    PubMed  Google Scholar 

  40. Jude, B., Goudemand, J., Dolle, I., Caron, C., Watel, A., Tiry, C., Cosson, A. Lupus anticoagulant: a clinical and laboratory study of 100 cases. Clin Lab Haematol 1988, 10, 41–51.

    PubMed  Google Scholar 

  41. Gastineau, D.A., Kazmier, F.J., Nichols, W.L., Bowie, E.J. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases. Am J Hematol 1985, 19, 265–275.

    PubMed  Google Scholar 

  42. Hughes, G.R. Thrombosis, abortion, cerebral disease, and the lupus anticoagulant (editorial). Br Med J 1983, 287, 1088–1089.

    Google Scholar 

  43. Ordi Ros, J., Vilardell Tarres, M., Barquinero Martinez, J., Selva O'Callaghan, A., Alijotas Reig, J., Bosch Gil, J. Fenomenos tromboticos y anticoagulante lupico en una serie de 112 enfermos con lupus eritematoso sistemico. Rev Clin Esp 1987, 180, 66–70.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Internal Medicine Services “Ntra. Sra. de La Candelaria” Hospital, Tenerife and “Ntra. Sra. del Pino”, Las Palmas, Spain

    J. Antolin, M. J. Amerigo, A. Cantabrana, A. Roces & P. Jimenez

Authors
  1. J. Antolin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. M. J. Amerigo
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Cantabrana
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. A. Roces
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. P. Jimenez
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Antolin, J., Amerigo, M.J., Cantabrana, A. et al. Systemic lupus erythematosus: Clinical manifestations and immunological parameters in 194 patients. Subgroup classification of SLE. Clin Rheumatol 14, 678–685 (1995). https://doi.org/10.1007/BF02207936

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02207936

Key words

Search

Navigation